Cholestatic and Autoimmune Liver Diseases
The Cholestatic and Autoimmune Liver Diseases Special Interest Group (SIG) is an international community of investigators and practitioner focusing on preventing diagnosing and treating cholestatic liver diseases, as well as diseases of the biliary tree (cholangiopathies). The SIG also strongly focuses on understanding the pathophysiology and on the genetics of cholestatic and biliary diseases as a way to identify novel therapeutic targets. The SIG promotes national and international collaborations and networks and registries to speed up the rate of discoveries and to facilitate clinical trials in an area that includes several rare diseases.
SIG Leadership
- Chair
- Cara Lynn Mack, MD, MD, FAASLD
- Vice Chair
- Craig Lammert, MD, MS
- Associate Lead
- Nadia Blessing, PA-C
- Communication Lead
- Monika Sarkar, MD, FAASLD, MAS
- Education Lead
- Rohit Mehtani, MBBS, MD, DM
- Trainee Lead
- Makeda Dawkins, MD
- At-Larges
- David N. Assis, MD
- Heather L. Francis, PhD, FAASLD
- Nanda Kerkar, MD
- Cynthia Levy, MD, FAASLD
- Staff Liaisons
- Akuender Dot, MPH
- Julie Hoffman, MBA
- Emerging Liver Advanced Practice Provider Program Awardee
- Kristen Knoph, PharmD